1
|
Quantitation of Acetyl Hexapeptide-8 in Cosmetics by Hydrophilic Interaction Liquid Chromatography Coupled to Photo Diode Array Detection. SEPARATIONS 2021. [DOI: 10.3390/separations8080125] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Bioactive peptides are gaining more and more popularity in the research and development of cosmetic products with anti-aging effect. Acetyl hexapeptide-8 is a hydrophilic peptide incorporated in cosmetics to reduce the under-eye wrinkles and the forehead furrows. Hydrophilic interaction liquid chromatography (HILIC) is the separation technique of choice for analyzing peptides. In this work, a rapid HILIC method coupled to photodiode array detection operated at 214 nm was developed, validated and used to determine acetyl-hexapeptide-8 in cosmetics. Chromatography was performed on a Xbridge® HILIC BEH analytical column using as mobile phase a 40 mM ammonium formate water solution (pH 6.5)-acetonitrile mixture 30:70, v/v at flow rate 0.25 mL min−1. The assay was linear over the concentration range 20 to 30 μg mL−1 for the cosmetic formulations and 0.004 to 0.007% (w/w) for the cosmetic cream. The limits of quantitation for acetyl hexapeptide-8 were 1.5 μg mL−1 and 0.002% (w/w) for the assay of cosmetic formulations and cosmetic creams, respectively. The method was applied to the analysis of cosmetic formulations and anti-wrinkle cosmetic creams.
Collapse
|
2
|
Isono A, Tsuji M, Sanada Y, Matsushita A, Masunaga S, Hirayama T, Nagasawa H. Design, Synthesis, and Evaluation of Lipopeptide Conjugates of Mercaptoundecahydrododecaborate for Boron Neutron Capture Therapy. ChemMedChem 2019; 14:823-832. [DOI: 10.1002/cmdc.201800793] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2018] [Revised: 01/23/2019] [Indexed: 12/26/2022]
Affiliation(s)
- Aoi Isono
- Laboratory of Pharmaceutical and Medicinal ChemistryGifu Pharmaceutical University Daigaku-nishi 1-25-4 Gifu-city Gifu 501-1196 Japan
| | - Mieko Tsuji
- Laboratory of Pharmaceutical and Medicinal ChemistryGifu Pharmaceutical University Daigaku-nishi 1-25-4 Gifu-city Gifu 501-1196 Japan
| | - Yu Sanada
- Particle Radiation BiologyInstitute for Integrated Radiation and Nuclear ScienceKyoto University 2-1010 Asashiro-Nishi Kumatori-cho, Sennan-gun Osaka 590-0494 Japan
| | - Akari Matsushita
- Laboratory of Pharmaceutical and Medicinal ChemistryGifu Pharmaceutical University Daigaku-nishi 1-25-4 Gifu-city Gifu 501-1196 Japan
| | - Shinichiro Masunaga
- Particle Radiation BiologyInstitute for Integrated Radiation and Nuclear ScienceKyoto University 2-1010 Asashiro-Nishi Kumatori-cho, Sennan-gun Osaka 590-0494 Japan
| | - Tasuku Hirayama
- Laboratory of Pharmaceutical and Medicinal ChemistryGifu Pharmaceutical University Daigaku-nishi 1-25-4 Gifu-city Gifu 501-1196 Japan
| | - Hideko Nagasawa
- Laboratory of Pharmaceutical and Medicinal ChemistryGifu Pharmaceutical University Daigaku-nishi 1-25-4 Gifu-city Gifu 501-1196 Japan
| |
Collapse
|
3
|
Janvier S, Cheyns K, Canfyn M, Goscinny S, De Spiegeleer B, Vanhee C, Deconinck E. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market. Talanta 2018; 188:795-807. [DOI: 10.1016/j.talanta.2018.06.023] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2018] [Revised: 06/06/2018] [Accepted: 06/08/2018] [Indexed: 12/29/2022]
|
4
|
Giannakou M, Varvaresou A, Kiriazopoulos E, Papageorgiou S, Kavvalou E, Tsirivas E, Panderi I. Quantification of oligopeptide-20 and oligopeptide-24 in cosmetic creams using hydrophilic interaction liquid chromatography with electrospray ionization mass spectrometry. SEPARATION SCIENCE PLUS 2018. [DOI: 10.1002/sscp.201800016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Maria Giannakou
- National and Kapodistrian University of Athens, Faculty of Pharmacy, Division of Pharmaceutical Chemistry; Laboratory of Pharmaceutical Analysis; Zografou Greece
| | - Athanasia Varvaresou
- Technological Education Institution of Athens, School of Health and Caring Professions, Department of Aesthetics and Cosmetology; Laboratory of Cosmetic Science; Greece
| | - Evaggelos Kiriazopoulos
- National and Kapodistrian University of Athens, Faculty of Pharmacy, Division of Pharmaceutical Chemistry; Laboratory of Pharmaceutical Analysis; Zografou Greece
| | - Spiridon Papageorgiou
- Technological Education Institution of Athens, School of Health and Caring Professions, Department of Aesthetics and Cosmetology; Laboratory of Cosmetic Science; Greece
| | - Eirini Kavvalou
- University of Crete, School of Medicine; Department of Dermatology; Heraklion Greece
| | - Efstathios Tsirivas
- Technological Education Institution of Athens, School of Health and Caring Professions, Department of Aesthetics and Cosmetology; Laboratory of Cosmetic Science; Greece
| | - Irene Panderi
- National and Kapodistrian University of Athens, Faculty of Pharmacy, Division of Pharmaceutical Chemistry; Laboratory of Pharmaceutical Analysis; Zografou Greece
| |
Collapse
|
5
|
Xu W, Jimenez RB, Mowery R, Luo H, Cao M, Agarwal N, Ramos I, Wang X, Wang J. A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins. MAbs 2017; 9:1186-1196. [PMID: 28805536 PMCID: PMC5627594 DOI: 10.1080/19420862.2017.1364326] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
During manufacturing and storage process, therapeutic proteins are subject to various post-translational modifications (PTMs), such as isomerization, deamidation, oxidation, disulfide bond modifications and glycosylation. Certain PTMs may affect bioactivity, stability or pharmacokinetics and pharmacodynamics profile and are therefore classified as potential critical quality attributes (pCQAs). Identifying, monitoring and controlling these PTMs are usually key elements of the Quality by Design (QbD) approach. Traditionally, multiple analytical methods are utilized for these purposes, which is time consuming and costly. In recent years, multi-attribute monitoring methods have been developed in the biopharmaceutical industry. However, these methods combine high-end mass spectrometry with complicated data analysis software, which could pose difficulty when implementing in a quality control (QC) environment. Here we report a multi-attribute method (MAM) using a Quadrupole Dalton (QDa) mass detector to selectively monitor and quantitate PTMs in a therapeutic monoclonal antibody. The result output from the QDa-based MAM is straightforward and automatic. Evaluation results indicate this method provides comparable results to the traditional assays. To ensure future application in the QC environment, this method was qualified according to the International Conference on Harmonization (ICH) guideline and applied in the characterization of drug substance and stability samples. The QDa-based MAM is shown to be an extremely useful tool for product and process characterization studies that facilitates facile understanding of process impact on multiple quality attributes, while being QC friendly and cost-effective.
Collapse
Affiliation(s)
- Weichen Xu
- a Analytical Sciences, MedImmune , One MedImmune Way, Gaithersburg , MD USA
| | - Rod Brian Jimenez
- a Analytical Sciences, MedImmune , One MedImmune Way, Gaithersburg , MD USA
| | - Rachel Mowery
- b Cell Culture and Fermentation Sciences, MedImmune , One MedImmune Way, Gaithersburg , MD USA
| | - Haibin Luo
- c Purification Process Sciences, MedImmune ; One MedImmune Way, Gaithersburg , MD USA
| | - Mingyan Cao
- a Analytical Sciences, MedImmune , One MedImmune Way, Gaithersburg , MD USA
| | - Nitin Agarwal
- b Cell Culture and Fermentation Sciences, MedImmune , One MedImmune Way, Gaithersburg , MD USA
| | - Irina Ramos
- c Purification Process Sciences, MedImmune ; One MedImmune Way, Gaithersburg , MD USA
| | - Xiangyang Wang
- a Analytical Sciences, MedImmune , One MedImmune Way, Gaithersburg , MD USA
| | - Jihong Wang
- a Analytical Sciences, MedImmune , One MedImmune Way, Gaithersburg , MD USA
| |
Collapse
|
6
|
Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges. Adv Drug Deliv Rev 2017; 110-111:52-64. [PMID: 27313077 DOI: 10.1016/j.addr.2016.06.002] [Citation(s) in RCA: 119] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2016] [Revised: 05/27/2016] [Accepted: 06/06/2016] [Indexed: 12/12/2022]
Abstract
Peptides are emerging as a new tool in drug and gene delivery. Peptide-drug conjugates and peptide-modified drug delivery systems provide new opportunities to avoid macrophage recognition and subsequent phagocytosis, cross endothelial and epithelial barriers, and enter the cytoplasm of target cells. Peptides are relatively small, low-cost, and are stable in a wide range of biological conditions. In this review, we summarize recent work in designing peptides to enhance penetration of biological barriers, increase cell uptake, and avoid the immune system. We highlight recent successes and contradictory results, and outline common emerging concepts and design rules. The development of sequence-structure-function relationships and standard protocols for benchmarking will be a key to progress in the field.
Collapse
|
7
|
The emergence of low-cost compact mass spectrometry detectors for chromatographic analysis. Trends Analyt Chem 2016. [DOI: 10.1016/j.trac.2016.04.025] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
8
|
Hashemi M, Yadegari A, Yazdanpanah G, Jabbehdari S, Omidi M, Tayebi L. Functionalized R9–reduced graphene oxide as an efficient nano-carrier for hydrophobic drug delivery. RSC Adv 2016. [DOI: 10.1039/c6ra13822e] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
A novel, stable, functionalized, and targeted graphene-based drug delivery system for smart transportation of hydrophobic agents is introduced.
Collapse
Affiliation(s)
- Mohaddeseh Hashemi
- Research Centre for Medical Nano-Technology and Tissue Engineering
- School of Advanced Technologies in Medicine
- Shahid Beheshti University of Medical Sciences
- Tehran
- Iran
| | - Amir Yadegari
- Research Centre for Medical Nano-Technology and Tissue Engineering
- School of Advanced Technologies in Medicine
- Shahid Beheshti University of Medical Sciences
- Tehran
- Iran
| | - Ghasem Yazdanpanah
- Research Centre for Medical Nano-Technology and Tissue Engineering
- School of Advanced Technologies in Medicine
- Shahid Beheshti University of Medical Sciences
- Tehran
- Iran
| | - Sayena Jabbehdari
- Research Centre for Medical Nano-Technology and Tissue Engineering
- School of Advanced Technologies in Medicine
- Shahid Beheshti University of Medical Sciences
- Tehran
- Iran
| | - Meisam Omidi
- Research Centre for Medical Nano-Technology and Tissue Engineering
- School of Advanced Technologies in Medicine
- Shahid Beheshti University of Medical Sciences
- Tehran
- Iran
| | - Lobat Tayebi
- Department of Developmental Sciences
- Marquette University School of Dentistry
- Milwaukee
- USA
- Department of Engineering Science
| |
Collapse
|
9
|
Stalmans S, Bracke N, Wynendaele E, Gevaert B, Peremans K, Burvenich C, Polis I, De Spiegeleer B. Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo. PLoS One 2015; 10:e0139652. [PMID: 26465925 PMCID: PMC4605843 DOI: 10.1371/journal.pone.0139652] [Citation(s) in RCA: 144] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2015] [Accepted: 08/16/2015] [Indexed: 11/24/2022] Open
Abstract
Cell-penetrating peptides (CPPs) are a group of peptides, which have the ability to cross cell membrane bilayers. CPPs themselves can exert biological activity and can be formed endogenously. Fragmentary studies demonstrate their ability to enhance transport of different cargoes across the blood-brain barrier (BBB). However, comparative, quantitative data on the BBB permeability of different CPPs are currently lacking. Therefore, the in vivo BBB transport characteristics of five chemically diverse CPPs, i.e. pVEC, SynB3, Tat 47-57, transportan 10 (TP10) and TP10-2, were determined. The results of the multiple time regression (MTR) analysis revealed that CPPs show divergent BBB influx properties: Tat 47-57, SynB3, and especially pVEC showed very high unidirectional influx rates of 4.73 μl/(g × min), 5.63 μl/(g × min) and 6.02 μl/(g × min), respectively, while the transportan analogs showed a negligible to low brain influx. Using capillary depletion, it was found that 80% of the influxed peptides effectively reached the brain parenchyma. Except for pVEC, all peptides showed a significant efflux out of the brain. Co-injection of pVEC with radioiodinated bovine serum albumin (BSA) did not enhance the brain influx of radiodionated BSA, indicating that pVEC does not itself significantly alter the BBB properties. A saturable mechanism could not be demonstrated by co-injecting an excess dose of non-radiolabeled CPP. No significant regional differences in brain influx were observed, with the exception for pVEC, for which the regional variations were only marginal. The observed BBB influx transport properties cannot be correlated with their cell-penetrating ability, and therefore, good CPP properties do not imply efficient brain influx.
Collapse
Affiliation(s)
- Sofie Stalmans
- Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
| | - Nathalie Bracke
- Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
| | - Evelien Wynendaele
- Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
| | - Bert Gevaert
- Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
| | - Kathelijne Peremans
- Department of Veterinary Medical Imaging and Small Animal Orthopaedics, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
| | - Christian Burvenich
- Department of Comparative Physiology and Biometrics, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
| | - Ingeborgh Polis
- Department of Medicine and Clinical Biology of Small Animals, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
| | - Bart De Spiegeleer
- Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
| |
Collapse
|